HyperSonnar
Analytics
Market
MarketEconomic calendarEarnings
Wallets
Copy tradingCoins
Account
Docs
Made with ❤️ by 0xLazard
DocsStatusTermsPrivacyX / Twitter
HyperSonnar is a read-only analytics tool built on public Hyperliquid on-chain data. Nothing here is investment advice. Positions shown are real tracked positions — coverage is partial and always displayed.
Earnings calendar

AbbVie Inc.

ABBVPharma & biotech
Official website
Latest available resultsQuarter ended June 30, 202610-Q · August 3, 2026
Filed with the SEC
Next reportOctober 29, 2026Analyst forecast 3.918 $/share
Period 1 of 58
Revenue
$16.99B
▲ +10.2% vs prior year% YoY
Net income
$3.61B
▲ +285.2% vs prior year% YoY
EPS
2.03$
▲ +290.4% vs prior year% YoY
Net margin
21.3%
▲ +15.2 percentage points vs prior year pp YoY
HYPERSONNAR
Revenue▲ +10.2 %
HYPERSONNAR
Margins (% of revenue)GrossOperatingNet
HYPERSONNAR
Net income▲ +285.2 %
HYPERSONNAR
EPS▲ +290.4 %
View financial tableQuarter ended June 30, 2026
MetricValueContext
Operations
Revenue$16.99B
Gross profit$12.70B74.7 %
Operating income$6.43B37.9 %
Net income$3.61B21.3 %
R&D—never filed
EPS (diluted)2.03 $
Balance sheet
Assets$135.12B
Liabilities$141.00B
Equity−$5.89B
Cash$6.57B
Capital
Shares outstanding1.77Bas of 2026-07-27
Public float—
View 10-Q filed 2026-08-03 on SEC ↗